TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) › Weighted Average Diluted SharesTEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2007-12-31: 830.00M2008-12-31: 820.00M2009-12-31: 896.00M2010-12-31: 921.00M2011-12-31: 893.00M2012-12-31: 873.00M2013-12-31: 850.00M2016-12-31: 9612017-12-31: 1.02B2018-12-31: 1.02B2019-12-31: 1.09B2020-12-31: 1.09B2021-12-31: 1.11B2022-12-31: 1.11B2023-12-31: 1.12B2024-12-31: 1.13B2025-12-31: 1.16B1.16B2007-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-311.16B+2.8%2026-02-03From 2025-01-012024-12-311.13B+1.1%2026-02-03From 2024-01-012023-12-311.12B+0.8%2026-02-03From 2023-01-012022-12-311.11B+0.3%2025-02-05From 2022-01-012021-12-311.11B+1.1%2024-02-12From 2021-01-012020-12-311.09B+0.4%2023-02-10From 2020-01-012019-12-311.09B+6.9%2022-02-09From 2019-01-012018-12-311.02B+0.5%2021-02-10From 2018-01-012017-12-311.02B+105723105.0%2020-02-21From 2017-01-012016-12-31961—2019-02-19From 2016-01-072013-12-31850.00M-2.6%2014-02-10From 2013-01-012012-12-31873.00M-2.2%2014-02-10From 2012-01-012011-12-31893.00M-3.0%2014-02-10From 2011-01-012010-12-31921.00M+2.8%2013-02-12From 2010-01-012009-12-31896.00M+9.3%2012-02-17From 2009-01-012008-12-31820.00M-1.2%2011-02-15From 2008-01-012007-12-31830.00M—2010-02-22From 2007-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)